Jesse Owens

Chief Scientific Advisor Komo Biosciences

Seminars

Tuesday 29th September 2026
Advancing Non-Viral Gene Editing by Leveraging Hyperactive Integrases to Efficiently Deliver Targeted Large Cargo
3:45 pm
  • Leveraging evolved phage integrases for non-viral, site-specific genomic integration to enhance safety and minimize off-target effects
  • Engineering a super-efficient non-viral delivery system for large DNA fragments to overcome current limitations and unlock complex gene therapies
  • Delivering exceptionally large therapeutic gene payloads (up to 16kb) to address complex multi-gene disorders and reduce manufacturing costs
Jesse Owens, Chief Scientific Advisor at Komo Biosciences, presenting innovative genome editing technologies and translational development strategies at the 7th Genome Editing Therapeutics Summit 2026